The precautions for use of Euroscan (finasteride 5mg) have been changed in accordance with the Food and Drug Safety Administration's (Drug Stability Policy Team No. 26641, effective date November 22, 2006) changes to the approval requirements for preparations containing "finasteride."
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Uroscan Tab.
Attachments are original documents and may be in Korean. English editions are labeled separately.
euroscanjeong.hwpEuroscan tablet (precautions for use) change (2006.12.04).hwp · 21 KBDownload ↓